BB Biotech Aktie 3838999 / CH0038389992
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Orderbuch | Analysen | |||||
Historisch |
22.09.2025 07:00:04
|
EQS-News: BB Biotech to be included in the SPI ESG Index
EQS-News: BB Biotech AG
/ Key word(s): ESG
Media release as at September 22, 2025 BB Biotech to be included in the SPI ESG Index BB Biotech AG announces that it will be included in the SPI ESG Index of the SIX Swiss Exchange as of today, September 22, 2025. This highlights the investment company’s long-standing commitment to responsible investing and sustainable corporate governance. Dr. Christian Koch, Head BB Biotech at Bellevue Asset Management, stated: «The inclusion in the SPI ESG Index is an important confirmation of our commitment to sustainability. It also underscores our strategic focus on biotechnology companies that create financial value while making an important contribution to society.» Launched in 2021, the SPI ESG Index includes companies from the Swiss Performance Index (SPI) that are selected by the independent sustainability agency Inrate based on strict criteria. This provides investors with a transparent benchmark for sustainable equity investments in Switzerland. The inclusion enhances BB Biotech’s visibility among ESG-oriented investors and underscores the long-term attractiveness of its portfolio.
For further information: Head BB Biotech E-Mail: ir@bbbiotech.com
www.bbbiotech.com
Company profile
22.09.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
Language: | English |
Company: | BB BIOTECH AG |
Schwertstrasse 6 | |
8200 Schaffhausen | |
Switzerland | |
Phone: | +41 52 624 08 45 |
E-mail: | info@bbbiotech.com |
Internet: | www.bbbiotech.ch |
ISIN: | CH0038389992 |
WKN: | A0NFN3 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Mailand, SIX |
EQS News ID: | 2200682 |
End of News | EQS News Service |
|
2200682 22.09.2025 CET/CEST
Nachrichten zu BB Biotech AG
15.10.25 |
Freundlicher Handel in Zürich: SPI zum Start des Mittwochshandels mit Gewinnen (finanzen.ch) | |
13.10.25 |
SPI-Titel BB Biotech-Aktie: So viel Verlust hätte ein Investment in BB Biotech von vor 10 Jahren eingebracht (finanzen.ch) | |
06.10.25 |
SPI-Wert BB Biotech-Aktie: So viel Verlust hätte ein BB Biotech-Investment von vor 5 Jahren eingebracht (finanzen.ch) | |
29.09.25 |
SPI-Wert BB Biotech-Aktie: So viel Verlust hätte ein Investment in BB Biotech von vor 3 Jahren eingebracht (finanzen.ch) | |
22.09.25 |
SPI-Wert BB Biotech-Aktie: So viel Verlust wäre bei einem Investment in BB Biotech von vor einem Jahr angefallen (finanzen.ch) | |
22.09.25 |
EQS-News: BB Biotech to be included in the SPI ESG Index (EQS Group) | |
22.09.25 |
EQS-News: BB Biotech wird in den SPI ESG Index aufgenommen (EQS Group) | |
15.09.25 |
SPI-Wert BB Biotech-Aktie: So viel hätten Anleger an einem BB Biotech-Investment von vor 10 Jahren verloren (finanzen.ch) |